Επιστημονικές Δημοσιεύσεις

Δημοσιεύσεις σε Διεθνή Ξενόγλωσσα Επιστημονικά Συγγράματα
-Complement deposition, C4d, on platelets is associated with vascular events in systemic lupus erythematosus
Elisabet Svenungsson, Johanna T Gustafsson, Giorgia Grosso, Marios Rossides, Iva Gunnarsson, Kerstin Jensen- Urstad,Anders Larsson, Kristina N Ekdahl, Bo Nilsson, Anders A Bengtsson, Christian Lood,
Rheumatology (Oxford). 2020 Nov 1;59(11):3264-3274

-Four Systemic Lupus Erythematosus Subgroups, Defined by Autoantibodies Status, Differ Regarding HLA- DRB1 Genotype Associations and Immunological and Clinical Manifestations
Lina-Marcela Diaz-Gallo, Vilija Oke, Emeli Lundström, Kerstin Elvin, Yee Ling Wu, Susanna Eketjäll, Agneta Zickert, Johanna T Gustafsson, Andreas Jönsen, Dag Leonard, Daniel J Birmingham, Gunnel Nordmark, Anders A Bengtsson, Lars Rönnblom, Iva Gunnarsson, Chack-Yung Yu, Leonid Padyukov, Elisabet Svenungsson
ACR Open Rheumatol 2022 Jan;4(1):27-39.

-Predictors of the first cardiovascular event in patients with Systemic Lupus Erythematosus: A prospective cohort study
Gustafsson J, Gunnarsson I, Jensen-Urstad K, Börjesson O, Pettersson S, Möller S, Guo-Zhong F , Hansson LO, Lundberg I, Larsson A, Svenungsson E. Arthritis Res Ther. 2009;11(6):R186.

-A STAT4 risk allele is associated with ischemic cerebrovascular events and antiphospholipid antibodies in Systemic Lupus Erythematosus
Svenungsson E, Gustafsson J, Leonard D, Sandling J, Gunnarsson I, Nordmark G, Jönsen A, Bengtsson A, Sturfelt G, Rantapää-Dahlqvist S, Elvin K, Sundin U, Garnier S, Sigurdsson S, Padyukov L, Syvänen A-C, Rönnblom L., Ann Rheum Dis. 2010;69(5):834-40

- Physical capacity and activity in patients with systemic lupus erythematosus and matched controls.
Eriksson K, Svenungsson E, Karreskog H, Gunnarsson I, Gustafsson J, Möller S, Pettersson S, Boström C. Scand J Rheumatol. 2011;41(4):290-7

-Risk factors for cardiovascular mortality in Systemic Lupus Erythematosus, a prospective cohort study

Gustafsson J, Simard J, Gunnarsson I, Elvin K, Lundberg IE, Hansson LO, Larsson A, Svenungsson E. Arthr Res Ther. 2012;14(2):R46

-HLA-DRB1*04/*13 alleles are associated with vascular disease and antiphospholipid antibodies in systemic lupus erythematosus
Lundström E, Gustafsson JT, Jönsen A, Leonard D, Zickert A, Elvin K, Sturfelt G, Nordmark G, Bengtsson A, Sundin U, Källberg H, Sandling JK, Syvänen AC, Klareskog L, Gunnarsson I, Rönnblom L, Padyukov L, Svenungsson E. Ann. Rheum. Dis 2013 Jun;72(6):1018-25

-Clinical manifestations and anti-phospholipid antibodies in 712 patients with systemic lupus erythematosus: evaluation of two diagnostic assays. Vikerfors A, Johansson A-B, Gustafsson JT, Jönsen A, Leonad D, Zickert A, Nordmark G, Bengtsson A, Rönnblom L, Gunnarsson I, Elvin K, Svenungsson E. Rheumatology. 2013 Mar;52(3):501-9.

-Autoantibodies to the functionally active RING-domain of Ro52/SSA associate with clinical activity in a subset of patients with lupus.

Kvarnström M, Dzikaite V, Ottosson L, Gustafsson JT, Gunnarsson I, Svenungsson E, Wahren-Herlenius M. Lupus. 2013;22(5):477-85

-Coronary Heart Disease in Systemic Lupus Erythematosus is associated with interferon regulatory factor 8 gene variants.
Leonard D, Svenungsson E, Sandling JK, Jönsen A, Bengtsson C, Wang C, Jensen-Urstad K, Bengtsson AA, Gustafsson JT, Gunnarsson I, Ortmann, W, Graham RR, Rantapää-Dahlqvist S, Nordmark G, Eloranta ML, Behrens TW, Syvänen AC, Rönnblom L. Circ Cardiovasc Genet. 2013 Jun;6(3):255-63

-Definitions of and contributions to cardiovascular disease in systemic lupus erythematosus

Gustafsson JT, Svenungsson E. Autoimmunity. 2014 Mar;47(2):67-76

-Cigarette smoking, antiphospholipid antibodies and vascular events in Systemic Lupus Erythematosus

Gustafsson JT, Gunnarsson I, Pettersson S, Zickert A, Vikerfors A, Möller S, Rönnelid J, Elvin K, Källberg H Svenungsson E. Ann. Rheum Dis 2015 Aug.;74(8):1537-43

-Increased levels of autoantibodies against apolipoprotein B-100 antigens are associated with cardiovascular disease in systemic lupus erythematosus
Svenungsson E, Engelbertsen D, Wigren M, Gustafsson JT, Gunnarsson I, Elvin K, Jensen-Urstad K, Fredrikson GN, Nilsson J. Clin Exp Immunl 2015 Sep;181(3):417-26

-Direct and indirect costs for systemic lupus erythematosus in Sweden. A nationwide health economic study based on five defined cohorts.
Jönsen A, Hjalte F, Willim M, Carlsson KS, Sjöwall C, Svenungsson E, Leonard D, Bengtsson C, Rantapää- Dahlqvist S, Pettersson S, Gunnarsson I, Zickert A, Gustafsson JT, Rönnblom L, Petersson IF, Bengtsson AA, Nived O.
Semin Arthritis Rheum. 2016 Jun;45(6):684-90

-Microparticles in the blood of patients with systemic lupus erythematosus (SLE): phenotypic characterization and clinical associations.
Mobarrez F, Vikerfors A, Gustafsson JT, Gunnarsson I, Zickert A, Larsson A, Pisetsky DS, Wallén H, Svenungsson E. Sci Rep. 2016 Oct 25;6:36025.
 

-A comparison of patients' and physicians' assessments of disease activity using the Swedish version of the Systemic Lupus Activity Questionnaire.
Pettersson S, Svenungsson E, Gustafsson J, Möller S, Gunnarsson I, Welin Henriksson E.
Scand J Rheumatol. 2017 Mar 15:1-10.

-Excess atherosclerosis in systemic lupus erythematosus,-A matter of renal involvement: Case control study of 281 SLE patients and 281 individually matched population controls.
Gustafsson JT, Herlitz Lindberg M, Gunnarsson I, Pettersson S, Elvin K, Öhrvik J, Larsson A, Jensen-Urstad K, Svenungsson E.
PLoS One. 2017 Apr 17;12(4)

​

-IFN- λ 1 with Th17 axis cytokines and IFN- α define different subsets in systemic lupus erythematosus

Oke V, Brauner S, Larsson A, Gustafsson J, Zickert A, Gunnarsson I, Svenungsson E.
Arthritis Res Ther. 2017 Jun 15;19(1): 1344-7.

 

-Depressed serum IgM levels in SLE are restricted to defined subgroups.
Grönwall C, Hardt U, Gustafsson JT, Elvin K, Jensen-Urstad K, Kvarnström M, Grosso G, Rönnelid J, Padykov L, Gunnarsson I, Silverman GJ, Svenungsson E. Clin Immunol. 2017 Oct;183:304-315.

 

-Cardiovascular disease in systemic lupus erythematosus is associated with increased levels of biomarkers reflecting receptor-activated apoptosis
Wigren M, Svenungsson E, Mattisson IY, Gustafsson JT, Gunnarsson I, Zickert A, Elvin K, Jensen-Urstad K, Bengtsson A, Gullstrand B, Fredrikson GN, Nilsson J. Atherosclerosis. 2018 Mar;270:1-7.

 

-TNF-α and plasma albumin as biomarkers of disease activity in systemic lupus erythematosus.
Idborg H, Eketjäll S, Pettersson S, Gustafsson JT, Zickert A, Kvarnström M, Oke V, Jakobsson PJ, Gunnarsson I, Svenungsson E. Lupus Sci Med. 2018 Jun 4;5(1)

​

Για ανάτυπα ή ηλεκτρονικά αντίγραφα καθώς και κάθε άλλη πληροφορία αναφορικά με την ερευνητική δραστηριότητα της Johanna Gustafsson, MD PhD παρακαλώ επικοινωνήστε στο med@gustafsson.gr